Kerry-Anne Rye Selected Research

HDL Lipoproteins

1/2022	HDL and Endothelial Function.
1/2021	High density lipoprotein-associated miRNA is increased following Roux-en-Y gastric bypass surgery for severe obesity.
1/2021	HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis.
10/2020	Protein Backbone and Average Particle Dynamics in Reconstituted Discoidal and Spherical HDL Probed by Hydrogen Deuterium Exchange and Elastic Incoherent Neutron Scattering.
1/2020	Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!
1/2019	High-density lipoproteins induce miR-223-3p biogenesis and export from myeloid cells: Role of scavenger receptor BI-mediated lipid transfer.
1/2019	Apolipoprotein A-I enhances insulin-dependent and insulin-independent glucose uptake by skeletal muscle.
1/2019	Apolipoprotein A-I Protects Against Pregnancy-Induced Insulin Resistance in Rats.
1/2018	Altered High Density Lipoprotein Composition in Behavioral Variant Frontotemporal Dementia.
12/2017	Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kerry-Anne Rye Research Topics

Disease

41	Atherosclerosis 01/2021 - 06/2002
35	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2005
34	Inflammation (Inflammations) 07/2021 - 01/2008
22	Type 2 Diabetes Mellitus (MODY) 07/2021 - 03/2009
21	Insulin Resistance 01/2022 - 03/2006
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 03/2006
8	Coronary Disease (Coronary Heart Disease) 01/2021 - 01/2009
7	Obesity 01/2022 - 11/2009
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 05/2010
6	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2008
5	Diabetes Mellitus 01/2018 - 08/2011
4	Body Weight (Weight, Body) 01/2022 - 05/2014
4	Ischemia 01/2020 - 04/2007
4	Hyperplasia 11/2019 - 04/2013
3	Weight Loss (Weight Reduction) 01/2021 - 11/2007
3	Myocardial Infarction 01/2021 - 07/2011
3	Atherosclerotic Plaque (Atheroma) 01/2021 - 07/2011
3	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 05/2005
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 08/2015 - 02/2008
3	Hypertriglyceridemia 05/2007 - 03/2006
2	Hypercholesterolemia 01/2022 - 06/2014
2	Hypertrophy 01/2022 - 06/2012
2	Adenocarcinoma 12/2020 - 01/2016
2	Chronic Renal Insufficiency 02/2019 - 01/2019
2	Kidney Diseases (Kidney Disease) 02/2019 - 04/2014
2	Chronic Kidney Failure (Chronic Renal Failure) 02/2019 - 04/2014
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2019 - 01/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 01/2013
2	Hypertension (High Blood Pressure) 01/2017 - 11/2012
2	Pre-Eclampsia (Preeclampsia) 01/2017 - 03/2014
2	Arteritis 01/2016 - 01/2008
2	Overweight 01/2016 - 01/2008
2	Hepatocellular Carcinoma (Hepatoma) 10/2014 - 12/2004
2	Necrosis 01/2012 - 08/2009

Drug/Important Bio-Agent (IBA)

44	HDL LipoproteinsIBA 01/2022 - 10/2004
38	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2022 - 06/2004
31	CholesterolIBA 12/2022 - 06/2004
25	LipidsIBA 01/2022 - 09/2006
19	HDL CholesterolIBA 01/2021 - 03/2006
18	ApolipoproteinsIBA 01/2021 - 03/2006
15	Lipoproteins (Lipoprotein)IBA 01/2022 - 10/2004
15	fibroblast growth factor 21IBA 01/2020 - 12/2012
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2012
12	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2011
11	Apolipoproteins E (ApoE)IBA 01/2021 - 06/2004
11	Cholesterol Ester Transfer ProteinsIBA 11/2019 - 06/2005
10	oxidized low density lipoproteinIBA 12/2022 - 05/2007
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2006
9	Atorvastatin (Lipitor)FDA Link 01/2019 - 11/2005
8	Fenofibrate (CiL)FDA LinkGeneric 07/2021 - 09/2006
8	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2004
6	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2014
6	Insulin (Novolin)FDA Link 02/2019 - 11/2009
5	LDL Lipoproteins (beta Lipoproteins)IBA 12/2022 - 12/2011
5	LDL CholesterolIBA 01/2022 - 12/2011
4	ATP-Binding Cassette Transporters (ABC Transporters)IBA 12/2016 - 02/2007
4	Proprotein Convertase 9IBA 04/2016 - 02/2008
4	LDL Receptors (LDL Receptor)IBA 01/2016 - 02/2008
3	Lipoprotein(a)IBA 01/2021 - 04/2016
3	Apolipoprotein A-II (Apolipoprotein A2)IBA 12/2020 - 08/2010
3	Messenger RNA (mRNA)IBA 01/2020 - 03/2014
3	anacetrapibIBA 11/2019 - 03/2015
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2017 - 04/2007
3	CytokinesIBA 12/2017 - 08/2009
3	SphingomyelinsIBA 01/2017 - 05/2007
3	baysilon (polydimethylsiloxane)IBA 01/2016 - 01/2008
3	Pharmaceutical PreparationsIBA 01/2016 - 01/2012
3	C-Reactive ProteinIBA 04/2015 - 05/2004
3	Phosphatidylcholines (Phosphatidylcholine)IBA 03/2014 - 11/2006
3	torcetrapibIBA 11/2012 - 08/2011
3	Apolipoprotein B-100 (Apo B 100)IBA 11/2009 - 09/2006
3	Serine (L-Serine)FDA Link 08/2008 - 05/2007
3	TransferasesIBA 08/2008 - 05/2007
3	thermozymocidin (myriocin)IBA 08/2008 - 05/2007
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2022
2	AndrogensIBA 01/2022 - 01/2022
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021 - 11/2007
2	Fatty Acid-Binding ProteinsIBA 11/2020 - 12/2012
2	HomocysteineIBA 11/2020 - 09/2006
2	MetalsIBA 01/2019 - 01/2016
2	Trinitrotoluene (TNT)IBA 01/2019 - 05/2014
2	Advanced Glycation End ProductsIBA 01/2018 - 01/2017
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2017 - 12/2011
2	AlbuminsIBA 01/2017 - 11/2016
2	IsotopesIBA 06/2016 - 11/2007
2	Apolipoproteins B (ApoB)IBA 04/2016 - 09/2006
2	Apolipoprotein C-IIIIBA 04/2016 - 01/2016
2	Cell Adhesion MoleculesIBA 01/2016 - 06/2002
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2016 - 01/2012
2	CalciumIBA 08/2015 - 10/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2014 - 11/2005
2	Heme Oxygenase-1IBA 01/2013 - 01/2012
2	Peroxidase (Myeloperoxidase)IBA 01/2013 - 05/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 05/2010
2	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2012 - 05/2010
2	p38 Mitogen-Activated Protein KinasesIBA 01/2012 - 03/2009

Therapy/Procedure

10	Therapeutics 01/2022 - 06/2005
5	Glycemic Control 01/2019 - 08/2011
2	Stents 12/2017 - 04/2013